Summary

The global Pharmaceutical Cellulose Derivative Excipient market is projected to grow from US$ 2,197.56 million in 2025 to US$ 4,004.45 million by 2032, at a CAGR of 9.39%, driven by critical product segments and diverse end‑use applications.
From a downstream perspective, Tablet accounted for 46.50% of 2025 revenue, surging to US$ 1,649.96 million by 2032 (CAGR: 7.43% from 2026–2032).
Pharmaceutical Cellulose Derivative Excipient leading manufacturers (including Roquette, JRS Pharma, Shin-Etsu Chemical Co., Ltd., Ashland, Asahi Kasei, Mingtai, Huzhou Zhanwang, Sunhere Pharmaceutical Excipients, Shandong HEAD, LOTTE Fine Chemical, etc.) dominate supply; the top five capture approximately 62.74% of global revenue.

Regional Outlook:
• North America rose from US$ 571.42 million in 2025 to a forecast US$ 952.21 million by 2032 (CAGR 7.95%).
• Asia‑Pacific will expand from US$ 953.80 million to US$1,962.17 million (CAGR 11.35%), led by China, Japan, South Korea, and Southeast Asia.
• Europe is set to grow from US$ 537.95 million to US$ 858.90 million (CAGR 7.24%).

Report Includes:
This definitive report equips business leaders, decision-makers, and stakeholders with a 360° view of the global Pharmaceutical Cellulose Derivative Excipient market, seamlessly integrating production capacity and sales performance across the value chain. It analyzes historical production, revenue, and sales data (2021–2025) and delivers forecasts through 2032, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets (North America, Europe, APAC, South America, and MEA) with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers (capacity, sales volume, revenue, margins, pricing strategies, and major customers) and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.

Market Segmentation

By Company
 Roquette
 Shin-Etsu Chemical Co., Ltd.
 Asahi Kasei
 Ashland
 JRS Pharma
 Sunhere Pharmaceutical Excipients
 Shandong HEAD
 Huzhou Zhanwang
 Mingtai
 Accent Microcell
 Lotte Chemicals
 Yingkou AODA Pharmaceuticals
 DFE Pharma
 Shandong Liaocheng E HUA Pharmaceutical Co., Ltd

Segment by Type
 Microcrystalline Cellulose MCC
 Hypromellose HPMC
 Hydroxypropyl Cellulose HPC
 CMC/CCS


Segment by Application
 Sustained Release Preparation
 Tablet
 Capsule

Production by Region
 North America
 Europe
 China
 Japan

Segment by Region
 North America
 United States
 Canada
 Mexico
 Asia-Pacific
 China
 Japan
 South Korea
 India
 Southeast Asia
 Rest of Asia

 Europe
 Germany
 France
 U.K.
 Italy
 Russia
 Rest of Europe

 Central and South America
 Brazil
 Argentina
 Rest of Central and South America

 Middle East & Africa
 Turkey
 GCC Countries
 Egypt
 South Africa

Chapter Outline
Chapter 1: Defines the Pharmaceutical Cellulose Derivative Excipient study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential
Chapter 2: Offers current market state, projects global revenue, sales, and production to 2032, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the manufacturer landscape: ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves
Chapter 4: Unlocks high margin product segments: compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities: evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application
Chapter 6: Maps global production capacity, utilization, and market share (2021–2032), identifies efficient hubs, reveals regulatory/trade policy impacts and bottlenecks
Chapter 7: North America: breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers
Chapter 8: Europe: analyses regional sales, revenue and market by by Type, by Application and manufacturers, flagging drivers and barriers
Chapter 9: Asia Pacific: quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas
Chapter 10: Central & South America: measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges
Chapter 11: Middle East and Africa: evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 12: Profiles manufacturers in depth: details product specs, capacity, sales, revenue, margins; top manufactures 2025 sales breakdowns by product type, by Application, by sales region SWOT analysis, and recent strategic developments
Chapter 13: Supply chain: analyses upstream raw materials and suppliers, manufacturing footprint and technology, cost drivers, plus downstream channels and distributor roles
Chapter 14: Market dynamics: explores drivers, restraints, regulatory impacts, and risk mitigation strategies
Chapter 15: Actionable conclusions and strategic recommendations

Why This Report:
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
• Allocate capital strategically to high growth regions (Chapters 7-11) and margin rich segments (Chapter 5).
• Negotiate from strength with suppliers (Chapter 13) and customers (Chapter 6) using cost and demand intelligence.
• Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 4 and 12).
• Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 13 and 14).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

ページTOPに戻る

Table of Contents

1 Study Coverage 1
1.1 Introduction to Pharmaceutical Cellulose Derivative Excipient: Definition, Properties, and Key Attributes 1
1.2 Market Segmentation by Type 2
1.2.1 Global Pharmaceutical Cellulose Derivative Excipient Market Size by Type, 2021 vs 2025 vs 2032 2
1.2.2 Microcrystalline Cellulose MCC 3
1.2.3 Hypromellose HPMC 4
1.2.4 Hydroxypropyl Cellulose HPC 4
1.2.5 CMC/CCS 5
1.3 Market Segmentation by Application 5
1.3.1 Global Pharmaceutical Cellulose Derivative Excipient Market Size by Application, 2021 vs 2025 vs 2032 6
1.3.2 Sustained Release Preparation 7
1.3.3 Tablet 7
1.3.4 Capsule 8
1.4 Assumptions and Limitations 9
1.5 Study Objectives 10
1.6 Years Considered 11
2 Executive Summary 12
2.1 Global Pharmaceutical Cellulose Derivative Excipient Revenue Estimates and Forecasts (2021-2032) 12
2.2 Global Pharmaceutical Cellulose Derivative Excipient Revenue by Region 13
2.2.1 Revenue Comparison: 2021 vs 2025 vs 2032 13
2.2.2 Global Revenue-Based Market Share by Region (2021-2032) 15
2.3 Global Pharmaceutical Cellulose Derivative Excipient Sales Estimates and Forecasts (2021-2032) 15
2.4 Global Pharmaceutical Cellulose Derivative Excipient Sales by Region 16
2.4.1 Sales Comparison: 2021 vs 2025 vs 2032 16
2.4.2 Global Sales Market Share by Region (2021-2032) 17
3 Global Production Analysis 18
3.1 Global Pharmaceutical Cellulose Derivative Excipient Production Capacity and Utilization Rates (2021–2032) 18
3.2 Production Comparison by Region: 2021 vs 2025 vs 2032 20
3.3 Regional Production Dynamics and Outlook 21
3.3.1 Historic Production by Region (2021-2026) 21
3.3.2 Forecasted Production by Region (2027-2032) 22
3.3.3 Production Market Share by Region (2021-2032) 23
3.3.4 Regulatory and Trade Policy Impact on Production 23
3.3.5 Production Capacity Enablers and Constraints 24
3.4 Key Regional Production Hubs 26
3.4.1 North America 26
3.4.2 Europe 27
3.4.3 China 28
3.4.4 Japan 29
4 Competitive Landscape 30
4.1 Global Pharmaceutical Cellulose Derivative Excipient Sales by Manufacturers 30
4.1.1 Global Sales Volume by Manufacturers (2021-2026) 30
4.1.2 Global Top Manufacturer’s Market Share by Sales Volume (2025) 32
4.2 Global Pharmaceutical Cellulose Derivative Excipient Manufacturer Revenue Rankings and Tiers 33
4.2.1 Global Revenue (Value) by Manufacturers (2021-2026) 33
4.2.2 Global Key Manufacturer Revenue Ranking (2025) 35
4.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3) 35
4.3 Manufacturer Profitability Profiles and Pricing Strategies 36
4.3.1 Gross Margin by Top Manufacturer (2021 vs. 2025) 36
4.3.2 Manufacturer-Level Price Trends (2021-2026) 37
4.4 Key Manufacturers Manufacturing Base and Headquarters 38
4.5 Global Pharmaceutical Cellulose Derivative Excipient Market Concentration and Dynamics 39
4.5.1 Global Market Concentration 39
4.5.2 Strategic Moves: M&A, Capacity Expansion, R&D Investment 39
5 Product Segmentation 41
5.1 Global Pharmaceutical Cellulose Derivative Excipient Sales Performance by Type 41
5.1.1 Global Pharmaceutical Cellulose Derivative Excipient Sales Volume by Type (2021-2032) 41
5.1.2 Global Pharmaceutical Cellulose Derivative Excipient Revenue by Type (2021-2032) 42
5.1.3 Global Average Selling Price (ASP) Trends by Type (2021-2032) 44
5.2 Product Technology Differentiation 44
6 Downstream Applications and Customers 46
6.1 Global Pharmaceutical Cellulose Derivative Excipient Sales by Application 46
6.1.1 Global Historical and Forecasted Sales by Application (2021-2032) 46
6.1.2 Global Sales Market Share by Application (2021-2032) 47
6.2 Global Pharmaceutical Cellulose Derivative Excipient Revenue by Application 47
6.2.1 Global Historical and Forecasted Revenue by Application (2021-2032) 47
6.2.2 Revenue-Based Market Share by Application (2021-2032) 49
6.3 Global Pricing Dynamics by Application (2021-2032) 50
6.4 Downstream Customer Analysis 50
6.4.1 Top Customers by Region 50
6.4.2 Top Customers by Application 52
7 North America 55
7.1 North America Sales Volume and Revenue (2021-2032) 55
7.2 North America Growth Accelerators and Market Barriers 56
7.3 North America Pharmaceutical Cellulose Derivative Excipient Market Size by Country 57
7.3.1 North America Revenue by Country 57
7.3.2 North America Sales Trends by Country 58
7.3.3 US 58
7.3.4 Canada 59
8 Europe 60
8.1 Europe Sales Volume and Revenue (2021-2032) 60
8.2 Europe Growth Accelerators and Market Barriers 61
8.3 Europe Pharmaceutical Cellulose Derivative Excipient Market Size by Country 62
8.3.1 Europe Revenue by Country 62
8.3.2 Europe Sales Trends by Country 62
8.3.3 Germany 63
8.3.4 France 64
8.3.5 U.K. 64
8.3.6 Italy 65
8.3.7 Russia 65
9 Asia-Pacific 66
9.1 Asia-Pacific Sales Volume and Revenue (2021-2032) 66
9.2 Asia-Pacific Pharmaceutical Cellulose Derivative Excipient Market Size by Region 67
9.2.1 Asia-Pacific Revenue by Region 67
9.2.2 Asia-Pacific Sales Trends by Region 68
9.3 Asia-Pacific Growth Accelerators and Market Barriers 68
9.4 China 70
9.5 Japan 71
9.6 South Korea 71
9.7 India 72
9.8 Southeast Asia 73
10 Central and South America 74
10.1 Central and South America Sales Volume and Revenue (2021-2032) 74
10.2 Central and South America Investment Opportunities and Key Challenges 75
10.3 Central and South America Pharmaceutical Cellulose Derivative Excipient Market Size by Country 76
10.3.1 Central and South America Revenue Trends by Country (2021 vs 2025 vs 2032) 76
10.3.2 Brazil 77
10.3.3 Argentina 77
11 Middle East and Africa 78
11.1 Middle East and Africa Sales Volume and Revenue (2021-2032) 78
11.2 Middle East and Africa Investment Opportunities and Key Challenges 79
11.3 Middle East and Africa Pharmaceutical Cellulose Derivative Excipient Market Size by Country 80
11.3.1 Middle East and Africa Revenue Trends by Country (2021 vs 2025 vs 2032) 80
11.3.2 Turkey 81
11.3.3 GCC Countries 82
11.3.4 Egypt 82
11.3.5 South Africa 83
12 Corporate Profile 84
12.1 Roquette 84
12.1.1 Roquette Corporation Information 84
12.1.2 Roquette Business Overview 85
12.1.3 Roquette Pharmaceutical Cellulose Derivative Excipient Product Models, Descriptions and Specifications 86
12.1.4 Roquette Pharmaceutical Cellulose Derivative Excipient Capacity, Sales, Price, Revenue and Gross Margin (2021-2026) 86
12.1.5 Roquette Recent Developments 87
12.2 Shin-Etsu Chemical Co., Ltd. 87
12.2.1 Shin-Etsu Chemical Co., Ltd. Corporation Information 87
12.2.2 Shin-Etsu Chemical Co., Ltd. Business Overview 88
12.2.3 Shin-Etsu Chemical Co., Ltd. Pharmaceutical Cellulose Derivative Excipient Product Models, Descriptions and Specifications 89
12.2.4 Shin-Etsu Chemical Co., Ltd. Pharmaceutical Cellulose Derivative Excipient Capacity, Sales, Price, Revenue and Gross Margin (2021-2026) 89
12.2.5 Shin-Etsu Chemical Co., Ltd. Recent Developments 90
12.3 Asahi Kasei 90
12.3.1 Asahi Kasei Corporation Information 90
12.3.2 Asahi Kasei Business Overview 91
12.3.3 Asahi Kasei Pharmaceutical Cellulose Derivative Excipient Product Models, Descriptions and Specifications 92
12.3.4 Asahi Kasei Pharmaceutical Cellulose Derivative Excipient Capacity, Sales, Price, Revenue and Gross Margin (2021-2026) 92
12.3.5 Asahi Kasei Recent Developments 93
12.4 Ashland 93
12.4.1 Ashland Corporation Information 93
12.4.2 Ashland Business Overview 94
12.4.3 Ashland Pharmaceutical Cellulose Derivative Excipient Product Models, Descriptions and Specifications 95
12.4.4 Ashland Pharmaceutical Cellulose Derivative Excipient Capacity, Sales, Price, Revenue and Gross Margin (2021-2026) 96
12.4.5 Ashland Recent Developments 97
12.5 JRS Pharma 97
12.5.1 JRS Pharma Corporation Information 97
12.5.2 JRS Pharma Business Overview 98
12.5.3 JRS Pharma Pharmaceutical Cellulose Derivative Excipient Product Models, Descriptions and Specifications 99
12.5.4 JRS Pharma Pharmaceutical Cellulose Derivative Excipient Capacity, Sales, Price, Revenue and Gross Margin (2021-2026) 100
12.5.5 JRS Pharma Recent Developments 100
12.6 Sunhere Pharmaceutical Excipients 101
12.6.1 Sunhere Pharmaceutical Excipients Corporation Information 101
12.6.2 Sunhere Pharmaceutical Excipients Business Overview 102
12.6.3 Sunhere Pharmaceutical Excipients Pharmaceutical Cellulose Derivative Excipient Product Models, Descriptions and Specifications 103
12.6.4 Sunhere Pharmaceutical Excipients Pharmaceutical Cellulose Derivative Excipient Capacity, Sales, Price, Revenue and Gross Margin (2021-2026) 103
12.6.5 Sunhere Pharmaceutical Excipients Recent Developments 104
12.7 Shandong HEAD 104
12.7.1 Shandong HEAD Corporation Information 104
12.7.2 Shandong HEAD Business Overview 105
12.7.3 Shandong HEAD Pharmaceutical Cellulose Derivative Excipient Product Models, Descriptions and Specifications 106
12.7.4 Shandong HEAD Pharmaceutical Cellulose Derivative Excipient Capacity, Sales, Price, Revenue and Gross Margin (2021-2026) 107
12.7.5 Shandong HEAD Recent Developments 107
12.8 Huzhou Zhanwang 108
12.8.1 Huzhou Zhanwang Corporation Information 108
12.8.2 Huzhou Zhanwang Business Overview 108
12.8.3 Huzhou Zhanwang Pharmaceutical Cellulose Derivative Excipient Product Models, Descriptions and Specifications 109
12.8.4 Huzhou Zhanwang Pharmaceutical Cellulose Derivative Excipient Capacity, Sales, Price, Revenue and Gross Margin (2021-2026) 109
12.9 Mingtai 110
12.9.1 Mingtai Corporation Information 110
12.9.2 Mingtai Business Overview 111
12.9.3 Mingtai Pharmaceutical Cellulose Derivative Excipient Product Models, Descriptions and Specifications 111
12.9.4 Mingtai Pharmaceutical Cellulose Derivative Excipient Capacity, Sales, Price, Revenue and Gross Margin (2021-2026) 112
12.9.5 Mingtai Recent Developments 112
12.10 Accent Microcell 113
12.10.1 Accent Microcell Corporation Information 113
12.10.2 Accent Microcell Business Overview 114
12.10.3 Accent Microcell Pharmaceutical Cellulose Derivative Excipient Product Models, Descriptions and Specifications 114
12.10.4 Accent Microcell Pharmaceutical Cellulose Derivative Excipient Capacity, Sales, Price, Revenue and Gross Margin (2021-2026) 115
12.11 LOTTE Fine Chemical 115
12.11.1 LOTTE Fine Chemical Corporation Information 115
12.11.2 LOTTE Fine Chemical Business Overview 116
12.11.3 LOTTE Fine Chemical Pharmaceutical Cellulose Derivative Excipient Product Models, Descriptions and Specifications 117
12.11.4 LOTTE Fine Chemical Pharmaceutical Cellulose Derivative Excipient Capacity, Sales, Price, Revenue and Gross Margin (2021-2026) 117
12.11.5 LOTTE Fine Chemical Recent Developments 118
12.12 Yingkou AODA Pharmaceuticals 118
12.12.1 Yingkou AODA Pharmaceuticals Corporation Information 118
12.12.2 Yingkou AODA Pharmaceuticals Business Overview 119
12.12.3 Yingkou AODA Pharmaceuticals Pharmaceutical Cellulose Derivative Excipient Product Models, Descriptions and Specifications 119
12.12.4 Yingkou AODA Pharmaceuticals Pharmaceutical Cellulose Derivative Excipient Capacity, Sales, Price, Revenue and Gross Margin (2021-2026) 120
12.13 DFE Pharma 120
12.13.1 DFE Pharma Corporation Information 120
12.13.2 DFE Pharma Business Overview 121
12.13.3 DFE Pharma Pharmaceutical Cellulose Derivative Excipient Product Models, Descriptions and Specifications 122
12.13.4 DFE Pharma Pharmaceutical Cellulose Derivative Excipient Capacity, Sales, Price, Revenue and Gross Margin (2021-2026) 123
12.13.5 DFE Pharma Recent Developments 123
12.14 Shandong Liaocheng E HUA Pharmaceutical Co., Ltd 124
12.14.1 Shandong Liaocheng E HUA Pharmaceutical Co., Ltd Corporation Information 124
12.14.2 Shandong Liaocheng E HUA Pharmaceutical Co., Ltd Business Overview 125
12.14.3 Shandong Liaocheng E HUA Pharmaceutical Co., Ltd Pharmaceutical Cellulose Derivative Excipient Product Models, Descriptions and Specifications 125
12.14.4 Shandong Liaocheng E HUA Pharmaceutical Co., Ltd Pharmaceutical Cellulose Derivative Excipient Capacity, Sales, Price, Revenue and Gross Margin (2021-2026) 126
13 Value Chain and Supply-Chain Analysis 127
13.1 Pharmaceutical Cellulose Derivative Excipient Industry Chain 127
13.2 Pharmaceutical Cellulose Derivative Excipient Upstream Materials Analysis 127
13.2.1 Raw Materials 127
13.2.2 Key Suppliers Market Share & Risk Assessment 128
13.3 Pharmaceutical Cellulose Derivative Excipient Integrated Production Analysis 129
13.3.1 Manufacturing Footprint Analysis 129
13.3.2 Production Technology Overview 129
13.3.3 Regional Cost Drivers 130
13.4 Pharmaceutical Cellulose Derivative Excipient Sales Channels and Distribution Networks 131
13.4.1 Sales Channels 131
13.4.2 Distributors 132
14 Pharmaceutical Cellulose Derivative Excipient Market Dynamics 133
14.1 Industry Trends and Evolution 133
14.2 Market Growth Drivers and Emerging Opportunities 134
14.3 Market Challenges, Risks, and Restraints 135
14.4 Impact of U.S. Tariffs 136
15 Key Findings in the Global Pharmaceutical Cellulose Derivative Excipient Study 137
16 Appendix 139
16.1 Research Methodology 139
16.1.1 Methodology/Research Approach 139
16.1.2 Data Source 142
16.2 Author Details 145